San Francisco Sentry Investment Group’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-86
Closed -$4K 931
2019
Q4
$4K Hold
86
﹤0.01% 658
2019
Q3
$4K Hold
86
﹤0.01% 658
2019
Q2
$4K Hold
86
﹤0.01% 659
2019
Q1
$4K Hold
86
﹤0.01% 675
2018
Q4
$4K Buy
+86
New +$3.53K ﹤0.01% 665
2017
Q4
Sell
-48
Closed -$2K 923
2017
Q3
$2K Buy
+48
New +$1.94K ﹤0.01% 848
2014
Q2
Sell
-83
Closed -$2K 641
2014
Q1
$2K Sell
83
-92
-53% -$1.99K ﹤0.01% 640
2013
Q4
$4K Sell
175
-28
-14% -$617 ﹤0.01% 584
2013
Q3
$4K Buy
203
+6
+3% +$128 ﹤0.01% 563
2013
Q2
$4K Buy
+197
New +$4.12K ﹤0.01% 565

Other funds holding HOLX

San Francisco Sentry Investment Group's HOLX Position: Q1 2020 in Review

San Francisco Sentry Investment Group sold out of Hologic (HOLX) in Q1 2020, closing a stake of 86 shares — an estimated $4K sold.

San Francisco Sentry Investment Group first reported a position in HOLX in Q2 2013 and held it in 10 quarters. The position peaked at $4K in Q4 2019. 485 funds tracked by Wall St. Rank hold HOLX as of Q1 2020.

  • San Francisco Sentry Investment Group reported no remaining Hologic position as of Q1 2020 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 86 Hologic shares in Q1 2020, an estimated $4K.
  • San Francisco Sentry Investment Group first reported a position in Hologic in Q2 2013 and held it in 10 quarters.
  • San Francisco Sentry Investment Group's Hologic position peaked at $4K in Q4 2019.
  • 485 funds tracked by Wall St. Rank held Hologic as of Q1 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2020, filed 9 Apr 2020.